← Back to Clinical Trials
Recruiting NCT04724603

Phage Safety Retrospective Cohort Study

Trial Parameters

Condition Bone and Joint Infection
Sponsor Hospices Civils de Lyon
Study Type OBSERVATIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2021-02-01
Completion 2022-08-01
Interventions
patients having had avderse event after phagotherapy for bone or joint or implant infection

Brief Summary

The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.

Eligibility Criteria

Inclusion Criteria: * patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event Exclusion Criteria: \-

Related Trials